JPS51118756A - Novel steroids * pharmaceutical composition containing same and preparation thereof - Google Patents

Novel steroids * pharmaceutical composition containing same and preparation thereof

Info

Publication number
JPS51118756A
JPS51118756A JP51030741A JP3074176A JPS51118756A JP S51118756 A JPS51118756 A JP S51118756A JP 51030741 A JP51030741 A JP 51030741A JP 3074176 A JP3074176 A JP 3074176A JP S51118756 A JPS51118756 A JP S51118756A
Authority
JP
Japan
Prior art keywords
preparation
pharmaceutical composition
composition containing
containing same
novel steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP51030741A
Other languages
English (en)
Japanese (ja)
Other versions
JPS625920B2 (sr
Inventor
Kiyashidei Furederitsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of JPS51118756A publication Critical patent/JPS51118756A/ja
Publication of JPS625920B2 publication Critical patent/JPS625920B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
JP51030741A 1975-03-21 1976-03-19 Novel steroids * pharmaceutical composition containing same and preparation thereof Granted JPS51118756A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB11819/75A GB1538227A (en) 1975-03-21 1975-03-21 16,16-disubstituted steroids of the androstene series

Publications (2)

Publication Number Publication Date
JPS51118756A true JPS51118756A (en) 1976-10-18
JPS625920B2 JPS625920B2 (sr) 1987-02-07

Family

ID=9993275

Family Applications (2)

Application Number Title Priority Date Filing Date
JP51030741A Granted JPS51118756A (en) 1975-03-21 1976-03-19 Novel steroids * pharmaceutical composition containing same and preparation thereof
JP60291811A Granted JPS61178920A (ja) 1975-03-21 1985-12-24 ４−エン−１６，１６−ジ置換−３−オンステロイドを含有する医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP60291811A Granted JPS61178920A (ja) 1975-03-21 1985-12-24 ４−エン−１６，１６−ジ置換−３−オンステロイドを含有する医薬組成物

Country Status (15)

Country Link
JP (2) JPS51118756A (sr)
AT (1) AT357700B (sr)
AU (1) AU501246B2 (sr)
BE (1) BE839751A (sr)
CA (1) CA1069498A (sr)
CH (2) CH621560A5 (sr)
DE (1) DE2610497C2 (sr)
DK (1) DK143757C (sr)
FR (2) FR2304345A1 (sr)
GB (1) GB1538227A (sr)
IE (1) IE42308B1 (sr)
IL (2) IL49132A (sr)
NL (1) NL184111C (sr)
SE (2) SE7603410L (sr)
ZA (1) ZA761324B (sr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147057A (en) * 1977-05-25 1978-12-21 Beecham Group Ltd Process for preparing steroid derivative and raw material using therefor
JPS62502543A (ja) * 1985-04-17 1987-10-01 シエ−リング　アクチエンゲゼルシヤフト 皮膚薬

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2943778A1 (de) * 1979-10-26 1981-05-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin 17 (alpha) -alkylsteroide, diese enthaltende praeparate sowie verfahren zu ihrer herstellung
JPS63300153A (ja) * 1987-05-29 1988-12-07 日本碍子株式会社 建築用ほうろうパネル
GB9021546D0 (en) * 1990-10-04 1990-11-21 Beecham Group Plc Novel composition
JPH06502161A (ja) * 1990-10-31 1994-03-10 ビーチャム・グループ・パブリック・リミテッド・カンパニー レチノイド浸透作用エンハンサーを含む局所用組成物
GB9205194D0 (en) * 1992-03-10 1992-04-22 Smithkline Beecham Plc Novel composition
JPWO2003051903A1 (ja) * 2001-12-19 2005-04-28 中外製薬株式会社 ７位及び１７位に置換基を有するアンドロスタン誘導体
CN108558975B (zh) * 2018-04-26 2021-03-02 昆明理工大学 12β-羟基-雄甾4,14-二烯-16-酮类化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853926A (en) * 1973-05-29 1974-12-10 Searle & Co 17{62 -hydroxy-16,16-dimethylester-4-en-3-one

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147057A (en) * 1977-05-25 1978-12-21 Beecham Group Ltd Process for preparing steroid derivative and raw material using therefor
JPS62502543A (ja) * 1985-04-17 1987-10-01 シエ−リング　アクチエンゲゼルシヤフト 皮膚薬

Also Published As

Publication number Publication date
DE2610497A1 (de) 1976-10-07
CH621560A5 (en) 1981-02-13
NL7602949A (nl) 1976-09-23
CA1069498A (en) 1980-01-08
AT357700B (de) 1980-07-25
JPS61178920A (ja) 1986-08-11
NL184111C (nl) 1989-04-17
IL58505A0 (en) 1980-01-31
SE7902256L (sv) 1979-03-13
NL184111B (nl) 1988-11-16
IL49132A0 (en) 1976-05-31
CH631996A5 (en) 1982-09-15
SE7603410L (sv) 1976-09-22
JPS6355488B2 (sr) 1988-11-02
BE839751A (fr) 1976-09-20
AU501246B2 (en) 1979-06-14
FR2304345A1 (fr) 1976-10-15
IE42308B1 (en) 1980-07-16
JPS625920B2 (sr) 1987-02-07
DE2610497C2 (de) 1986-10-16
DK123476A (da) 1976-09-22
GB1538227A (en) 1979-01-10
IE42308L (en) 1976-09-21
AU1220776A (en) 1977-09-22
IL49132A (en) 1980-05-30
DK143757C (da) 1982-03-22
FR2304345B1 (sr) 1980-11-07
ATA191376A (de) 1979-12-15
DK143757B (da) 1981-10-05
FR2445340A1 (fr) 1980-07-25
ZA761324B (en) 1977-02-23
FR2445340B1 (sr) 1983-02-11

Similar Documents

Publication Publication Date Title
IL51816A0 (en) Novel steroids their preparation and pharmaceutical compositions containing them
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
IL50632A0 (en) Pyridinyl-2(1h)-pyridinones their preparation and pharmaceutical compositions containing them
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL51087A0 (en) New polyhalogeno-steroids their manufacture and pharmaceutical compositions containing them
ZA763917B (en) Pharmaceutical compositions and compounds
IL51040A0 (en) Novel pyrimidone compounds and pharmaceutical compositions containing these
JPS5262263A (en) Esteranic steroid and pharmaceutical composition thereof
IL50631A (en) 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
GB1544191A (en) Acylaminopiperidines processes for their preparation and pharmaceutical compositions containing them
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
JPS51118756A (en) Novel steroids * pharmaceutical composition containing same and preparation thereof
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
IL48453A0 (en) Novel quinuclidine derivatives and pharmaceutical compositions containing them
IL49122A (en) L-pyroglutamyl-l-histidyl-3-alkyl-prolineamide processes for their preparation and therapeutic compositions containing the same
IL49991A (en) L-pyroglutamyl-l-prolinamide, its preparation and pharmaceutical compositions containing it
IL53058A0 (en) Novel steroids of the spiroxane series their preparation and pharmaceutical compositions containing them
JPS5257154A (en) Naphthalene derivatives * pharmaceutical composition and preparation thereof
GB1552460A (en) Diphenylacetamide derivatives processes for their preparation and pharmaceutical compositions containing them
JPS5265260A (en) Steroids and preparation thereof*
IL54073A0 (en) Solid pharmaceutical compositions containing steroids and their preparation